Skip to Main Content

Author Details

Olivia M Lucero
Oregon Health & Science University
2009
15
7
PMIDPaper TitleJournal TitlePublished Year
37199721Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.Clin Cancer Res2023
36230844Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells.Cancers (Basel)2022
35343367Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.Cancer Biol Ther2022
29965855Quinacrine-Associated Punctate Palmar Keratoderma.J Clin Rheumatol2021
35036221Herpes Zoster Presenting As Cutaneous Vasculitis in the Upper Extremity.Cureus2021
32843430Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.Cold Spring Harb Mol Case Stud2020
30810217Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure.Br J Haematol2019
28734003Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum.Br J Dermatol2018
30547074Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative.JAAD Case Rep2018
29630158A case illustrating successful eradication of recurrent, aggressive basal cell carcinoma located in a scar with vismodegib.Dermatol Online J2018
28283772Identification, genetic testing, and management of hereditary melanoma.Cancer Metastasis Rev2017
24865425WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.J Clin Invest2014
22234612Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.Sci Signal2012
20603725A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.Curr Oncol Rep2010
19052537The V-ATPase B1-subunit promoter drives expression of Cre recombinase in intercalated cells of the kidney.Kidney Int2009
  • 1 - 15 of 15

Recommended Authors

Helen T Michael
National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 0
Michael G Ozawa
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Raghwa Sharma
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 0
Caroline C Kim
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 1
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Shadmehr Demehri
Massachusetts General Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 4
Marcory C R F van Dijk
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Antonio Subtil
Royal Jubilee Hospital, University of British Columbia
Career Start Year 2000
Number of shared co-authors 0
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1999
Number of shared co-authors 0
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 1
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Caroline Hutter
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1996
Number of shared co-authors 0
Rubeta N Matin
Oxford University Hospitals NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 0
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 3
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 0
Timothy M Kuzel
548377Rush University Medical Center
Career Start Year 1988
Number of shared co-authors 1
Reinhard Dummer
University Hospital Zurich
Career Start Year 1988
Number of shared co-authors 0
Grant A McArthur
University of Melbourne
Career Start Year 1986
Number of shared co-authors 0
Anthony E Oro
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 1
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Justin J Leitenberger
Oregon Health and Science University
Co-authored papers 3
Daniel R Clayburgh
Oregon Health & Science University
Co-authored papers 2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 2
Sophia Jeng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Peter E Andersen
Oregon Health & Science University
Co-authored papers 2
Bill H Chang
Oregon Health and Science University
Co-authored papers 2
Molly Kulesz-Martin
Oregon Health & Science University
Co-authored papers 2
Myles Vigoda
Oregon Health & Science University
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Carolyn Hale
Oregon Health and Science University
Co-authored papers 1
Mike Palazzolo
Washington University School of Medicine
Co-authored papers 1
Aurora S Blucher
Knight Cancer Institute, Oregon Health Sciences University
Co-authored papers 1
Jone E Sampson
Oregon Health & Science University
Co-authored papers 1
Danielle McClanahan
Center for Health and Healing Building 1
Co-authored papers 1
Guang Fan
Oregon Health and Science University
Co-authored papers 1
Ryan Li
Oregon Health & Science University
Co-authored papers 1
Xiaoming Ouyang
Stanford Cardiovascular Institute, Stanford University
Co-authored papers 1
Anna Bar
Oregon Health & Science University
Co-authored papers 1
Christina L Zheng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
James Jacobs
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Carolyn Hale
Oregon Health & Science University
Co-authored papers 1
Nathaniel Evans
Co-authored papers 1
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers 1
Daniel Petrisor
Thomas Jefferson University
Co-authored papers 1
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Georgina V Long
Co-authored papers 1
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Chase Mathieson
Oregon Health & Science University
Co-authored papers 1
Kara Johnson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Jennifer Jennings
Oregon Health & Science University
Co-authored papers 1
Release 1.2